Medistim ASA Statistics
Total Valuation
Medistim ASA has a market cap or net worth of EUR 327.94 million. The enterprise value is 314.29 million.
Market Cap | 327.94M |
Enterprise Value | 314.29M |
Important Dates
The last earnings date was Friday, May 9, 2025.
Earnings Date | May 9, 2025 |
Ex-Dividend Date | May 9, 2025 |
Share Statistics
Current Share Class | 18.25M |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.06% |
Shares Change (QoQ) | -0.27% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 12.61M |
Valuation Ratios
The trailing PE ratio is 30.35 and the forward PE ratio is 28.87.
PE Ratio | 30.35 |
Forward PE | 28.87 |
PS Ratio | 6.17 |
PB Ratio | 7.99 |
P/TBV Ratio | 9.26 |
P/FCF Ratio | 27.88 |
P/OCF Ratio | 26.67 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.99, with an EV/FCF ratio of 26.72.
EV / Earnings | 29.08 |
EV / Sales | 6.00 |
EV / EBITDA | 19.99 |
EV / EBIT | 22.89 |
EV / FCF | 26.72 |
Financial Position
The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.06.
Current Ratio | 3.91 |
Quick Ratio | 2.52 |
Debt / Equity | 0.06 |
Debt / EBITDA | 0.14 |
Debt / FCF | 0.20 |
Interest Coverage | 194.08 |
Financial Efficiency
Return on equity (ROE) is 27.42% and return on invested capital (ROIC) is 21.22%.
Return on Equity (ROE) | 27.42% |
Return on Assets (ROA) | 17.26% |
Return on Invested Capital (ROIC) | 21.22% |
Return on Capital Employed (ROCE) | 31.82% |
Revenue Per Employee | 344,895 |
Profits Per Employee | 70,174 |
Employee Count | 154 |
Asset Turnover | 1.05 |
Inventory Turnover | 0.73 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.33% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +8.33% |
50-Day Moving Average | 15.45 |
200-Day Moving Average | 14.06 |
Relative Strength Index (RSI) | 59.33 |
Average Volume (20 Days) | 104 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medistim ASA had revenue of EUR 53.11 million and earned 10.81 million in profits. Earnings per share was 0.59.
Revenue | 53.11M |
Gross Profit | 42.62M |
Operating Income | 13.91M |
Pretax Income | 14.10M |
Net Income | 10.81M |
EBITDA | 15.16M |
EBIT | 13.91M |
Earnings Per Share (EPS) | 0.59 |
Balance Sheet
The company has 16.13 million in cash and 2.30 million in debt, giving a net cash position of 13.83 million.
Cash & Cash Equivalents | 16.13M |
Total Debt | 2.30M |
Net Cash | 13.83M |
Net Cash Per Share | n/a |
Equity (Book Value) | 41.02M |
Book Value Per Share | 2.25 |
Working Capital | 30.78M |
Cash Flow
In the last 12 months, operating cash flow was 12.30 million and capital expenditures -533,668, giving a free cash flow of 11.76 million.
Operating Cash Flow | 12.30M |
Capital Expenditures | -533,668 |
Free Cash Flow | 11.76M |
FCF Per Share | n/a |
Margins
Gross margin is 80.25%, with operating and profit margins of 26.19% and 20.35%.
Gross Margin | 80.25% |
Operating Margin | 26.19% |
Pretax Margin | 26.54% |
Profit Margin | 20.35% |
EBITDA Margin | 28.55% |
EBIT Margin | 26.19% |
FCF Margin | 22.15% |
Dividends & Yields
This stock pays an annual dividend of 0.51, which amounts to a dividend yield of 2.92%.
Dividend Per Share | 0.51 |
Dividend Yield | 2.92% |
Dividend Growth (YoY) | 33.88% |
Years of Dividend Growth | n/a |
Payout Ratio | 67.07% |
Buyback Yield | -0.06% |
Shareholder Yield | 2.86% |
Earnings Yield | 3.30% |
FCF Yield | 3.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |